2.0
24 Jul 2024
Former employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
- ESOP Program - Opportunity for Advancement - Experience with ASC 606 recognition and clinical trial
Cons
- Lack of guidance from leadership around understanding 'why' things were performed - Not many opportunities to build with the team - Forecasts would be heavily scrutinized and it felt like we were more focused on backing into a number rather than creating a new one. - Sometimes it felt that people were promoted because they were willing to endure difficult people as opposed to challenging the status quo